These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 10163324

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Resource use and costs of patients with glaucoma or ocular hypertension: a one-year study based on retrospective chart review in the Netherlands.
    Oostenbrink JB, Rutten-van Mölken MP, Sluyter-Opdenoordt TS.
    J Glaucoma; 2001 Jun; 10(3):184-91. PubMed ID: 11442180
    [Abstract] [Full Text] [Related]

  • 4. Electrophysiological and psychophysical testing of vision in glaucoma.
    Bodis-Wollner I.
    Surv Ophthalmol; 1989 Feb; 33 Suppl():301-7. PubMed ID: 2655143
    [Abstract] [Full Text] [Related]

  • 5. Resource use and costs for a glaucoma screening program in Austria: an 8-year review: a cost-consequence analysis based on the Salzburg-Moorfields Collaborative Glaucoma Study.
    Hitzl W, Ortner C, Hornykewycz K, Grabner G, Reitsamer HA.
    Eur J Ophthalmol; 2006 Feb; 16(1):92-9. PubMed ID: 16496251
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A revisit: ocular hypertension, glaucoma suspect, preglaucoma, or glaucoma?
    Johnson TD, Zimmerman TJ.
    Ann Ophthalmol; 1985 Jul; 17(7):390-1. PubMed ID: 4037597
    [No Abstract] [Full Text] [Related]

  • 9. Glaucoma screening. A cost-effectiveness analysis.
    Gottlieb LK, Schwartz B, Pauker SG.
    Surv Ophthalmol; 1983 Jul; 28(3):206-26. PubMed ID: 6422576
    [Abstract] [Full Text] [Related]

  • 10. [Announcement--a stressful winter for ophthalmologists].
    Mehrle G.
    Klin Monbl Augenheilkd; 2000 Feb; 216(2):A25. PubMed ID: 10730218
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Diagnosis and treatment of ocular hypertension].
    Sun YY, Chen WW, Wang NL.
    Zhonghua Yan Ke Za Zhi; 2016 Jul; 52(7):542-6. PubMed ID: 27531115
    [Abstract] [Full Text] [Related]

  • 13. Awareness of sight-testing entitlements in patients referred for suspected glaucoma.
    Ratnarajan G, Somner J, Coombes E, Jones A, Bourne R.
    Eye (Lond); 2014 Apr; 28(4):504-5. PubMed ID: 24503726
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of ocular hypertension: is it cost effective?
    Tuulonen A.
    Curr Opin Ophthalmol; 2016 Mar; 27(2):89-93. PubMed ID: 26569531
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A limited free eye test?
    Harrison R.
    Practitioner; 1997 Apr; 241(1573):171. PubMed ID: 9206285
    [No Abstract] [Full Text] [Related]

  • 20. How prostaglandins have changed the medical approach to glaucoma and its costs: an observational study of 2228 patients treated with glaucoma medications.
    De Natale R, Draghi E, Dorigo MT.
    Acta Ophthalmol Scand; 2004 Aug; 82(4):393-6. PubMed ID: 15291930
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.